Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmaceutical distributor McKesson (NYSE:MCK) has earned a respected four-star ranking.

With that in mind, let's take a closer look at McKesson and see what CAPS investors are saying about the stock right now.

McKesson facts

Headquarters (founded)

San Francisco (1833)

Market Cap

$21.9 billion

Industry

Health care distributors

Trailing-12-Month Revenue

$123.2 billion

Management

Chairman/CEO John Hammergren
CFO Jeffrey Campbell

Return on Equity (average, past 3 years)

18.8%

Cash/Debt

$2.8 billion / $3.6 billion

Dividend Yield

0.9%

Competitors

AmerisourceBergen (NYSE:ABC)Cardinal Health (NYSE:CAH)Owens & Minor (NYSE:OMI)

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 96% of the 619 members who have rated McKesson believe the stock will outperform the S&P 500 going forward.

Just yesterday, one of those Fools, huddaman, tapped McKesson as a particularly solid long-term selection:

[McKesson's] growth has been slow over last 5 years. Not as good or anywhere near the historic company performance. ... However, their ROIC and ROE are [very high], and they are using excess cash to buy back shares. Shares outstanding down from [306M in 2006] to [236M today]. That's really incredibly awesome. The stock no wonder grew approx 100% between 2006 and today (with dividends). They can repeat this performance again.

If you want market-thumping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite a strong four-star rating, McKesson may not be your top choice.

We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.